Evidence map›Paper›PMID 38482465›Full record

ArticleCase reports in immunology2024

Autoreactive Antibodies Associated with Castleman Disease Triad.

Jacqueline A Turner, Ali Hakimi, Hannah Lee, Jeffrey T Schowinsky, Jeffrey M Sippel, Bradford J Siegele, Raul M Torres, William A Robinson

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jacqueline A TurnerDivision of Medical Oncology, University of Colorado Anschutz School of Medicine, Anschutz Medical Campus, Aurora, CO, USA.ORCID https://orcid.org/0000-0002-6638-1956
Ali HakimiUniversity of Colorado Anschutz School of Medicine, Anschutz Medical Campus, Aurora, CO, USA.
Hannah LeeDivision of Hematology and Oncology, Olive View-University of California Los Angeles Medical Center, Sylmar, CA, USA.
Jeffrey T SchowinskyDepartment of Pathology, University of Colorado School of Medicine, Aurora, CO, USA.
Jeffrey M SippelDivision of Pulmonology, University of Colorado Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
Bradford J SiegeleDepartment of Pathology, University of Colorado School of Medicine, Aurora, CO, USA.
Raul M TorresDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO, USA.
William A RobinsonDivision of Medical Oncology, University of Colorado Anschutz School of Medicine, Anschutz Medical Campus, Aurora, CO, USA.ORCID https://orcid.org/0000-0003-1875-9691
University of Colorado Denver · USUniversity of Colorado Anschutz Medical Campus · USUniversity of California, Los Angeles · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Castleman triad has been described in a select few patients presenting with a retroperitoneal mass, mucocutaneous pemphigus vulgaris, and bronchiolitis obliterans. Here, we describe the Castleman triad in a 19-year-old male with unicentric hyaline vascular type Castleman disease (HV-CD). This patient presented with an array of positive antibodies, including anti-cyclic citrullinated peptide, anti-double-stranded DNA, and Sjogren's IgG. Interestingly, the patient's rheumatologic symptoms resolved after tumor resection, while his antibody profile remained relatively unchanged. HV-CD, with a triad presentation, was thought to be from a paraneoplastic syndrome secondary to an underlying lymphoproliferative disorder. The findings presented here identify multiple autoantibodies potentially contributing to this patient's presentation with HV-CD.

Identifiers

PMID38482465
PMCPMC10937079
OpenAlexW4392501491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.